MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancer-Reference-Cited by-同舟云学术

MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancer

Published:2021-06 Issue: Volume:21 Page:340-355
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Singh Hans Martin,Leber Mathias Felix,Bossow Sascha,Engeland Christine E.,Dessila Jan,Grossardt Christian,Zaoui Karim,Bell John C.,Jäger Dirk,von Kalle Christof,Ungerechts Guy

Funder

Helmholtz Association of German Research Centres

Ruprecht Karls Universität Heidelberg Medizinische Fakultät Heidelberg

Stiftung Deutsche Krebshilfe

German Cancer Research Centre

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference97 articles.

1. Pancreatic adenocarcinoma;Ryan;N. Engl. J. Med.,2014

2. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial;Burris;J. Clin. Oncol.,1997

3. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer;Conroy;N. Engl. J. Med.,2011

4. Metastatic pancreatic cancer: American Society of Clinical Oncology clinical practice guideline;Sohal;J. Clin. Oncol.,2016

5. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): A multicentre, open-label, randomised, phase 3 trial;Neoptolemos;Lancet,2017

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing Pancreatic Cancer Therapy: The Promise of Immune Stimulatory Oncolytic Viruses;International Journal of Molecular Sciences;2024-09-13

2. MicroRNAs: emerging biomarkers and therapeutic targets in pancreatic cancer;Frontiers in Molecular Biosciences;2024-09-03

3. miRNA-Mediated Mechanisms in the Generation of Effective and Safe Oncolytic Viruses;Pharmaceutics;2024-07-25

4. Genetically modified ZIKA virus as a microRNA-sensitive oncolytic virus against central nervous system tumors;Molecular Therapy;2024-02

5. Onkolytische Viren zur Behandlung von Krebserkrankungen;BIOspektrum;2023-10